Forecasted Opportunity
Cooperative Agreement to Support Regulatory Research Related to the 2023 Prescription Drug User Fee Act
The goal of this collaboration is to advance research in several key areas of interest to FDA and external stakeholders by convening stakeholders with diverse expertise, and to inform and support the advancement of regulatory science priorities, particularly those identified in PDUFA VII. There will be substantial Federal scientific or programmatic involvement in assisting, guiding, coordinating, and participating in project activities, which makes a cooperative agreement the most appropriate mechanism.
Post Date:December 1, 2022
Close Date:March 13, 2023
Last Updated Date:December 1, 2022
Opportunity ID: 344522
Opportunity Number: RFA-FD-23-023
Agency Name: Food and Drug Administration
Eligible Applicants:
0 - State governments1 - County governments
2 - City or township governments
4 - Special district goverments
5 - Independent school districts
6 - Public and State controlled institutions of higher education
7 - Native American tribal governments (Federally recognized)
8 - Public housing authorities/Indian housing authorities
11 - Native American tribal organizations (other than Federally recognized tribal governments)
12 - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education
13 - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education
20 - Private institutions of higher education
22 - For-profit organizations other than small businesses
23 - Small businesses
25 - Others
